{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:35Z","timestamp":1793978855806,"version":"4.8.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21977115"],"award-info":[{"award-number":["21977115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFE0105400"],"award-info":[{"award-number":["2022YFE0105400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119222","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:32:49Z","timestamp":1786548769000},"page":"119222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Recent advances in small-molecule NLRP3 inhibitors derived from natural products"],"prefix":"10.1016","volume":"319","author":[{"given":"ShiWei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KeXue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GuoYi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShunYu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanabe","family":"Genzoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-5706","authenticated-orcid":false,"given":"WeiJia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119222_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib2","first-page":"515","article-title":"Paenofilorin alleviates depression by inhibiting the activation of NLRP3 inflammasome via promoting mitochondrial autophagy","volume":"22","author":"Su","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejmech.2026.119222_bib4","first-page":"535","article-title":"Organellar homeostasis and innate immune sensing","volume":"22","author":"Harapas","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejmech.2026.119222_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119222_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2026.119222_bib7","first-page":"1036","article-title":"Natural products targeting NLRP3 inflammasome for metabolic dysfunction-associated fatty liver disease: the known unknowns","volume":"23","author":"Meng","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib8","first-page":"224","article-title":"Yang-Gan Jiangmei formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-\u03baB\/NLRP3 signaling pathway","volume":"22","author":"Wu","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jbspin.2008.04.001","article-title":"Anakinra: new therapeutic approach in children with familial Mediterranean fever resistant to colchicine","volume":"75","author":"Roldan","year":"2008","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.ejmech.2026.119222_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1586\/eci.10.66","article-title":"Canakinumab: a human anti-IL-1\u03b2 monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes","volume":"6","author":"Church","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.ejmech.2026.119222_bib11","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.drudis.2021.02.018","article-title":"Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases","volume":"26","author":"Vong","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119222_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nchem.2479","article-title":"Counting on natural products for drug design","volume":"8","author":"Rodrigues","year":"2016","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrd.2018.53","article-title":"Chemical probes and drug leads from advances in synthetic planning and methodology","volume":"17","author":"Gerry","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119222_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cbpa.2010.02.018","article-title":"Privileged scaffolds for library design and drug discovery","volume":"14","author":"Welsch","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119222_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2018.12.007","article-title":"Natural product derived privileged scaffolds in drug discovery","volume":"52","author":"Davison","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119222_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/ijms20020360","article-title":"Dual role of triptolide in interrupting the NLRP3 inflammasome pathway to attenuate cardiac fibrosis","volume":"20","author":"Pan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119222_bib17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2017.08.036","article-title":"A new mechanism of inhibition of IL-1\u03b2 secretion by celastrol through the NLRP3 inflammasome pathway","volume":"814","author":"Xin","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib18","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S445788","article-title":"Andrographolide attenuates NLRP3 inflammasome activation and airway inflammation in exacerbation of chronic obstructive pulmonary disease","volume":"18","author":"Yu","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.119222_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1096\/fj.201901537R","article-title":"Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly","volume":"34","author":"Shi","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2026.119222_bib20","first-page":"486","article-title":"Reynosin protects neuronal cells from microglial neuroinflammation by suppressing NLRP3 inflammasome activation mediated by NADPH oxidase","volume":"22","author":"Yang","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41401-023-01212-5","article-title":"Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice","volume":"45","author":"Shao","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2026.119222_bib22","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/bph.16036","article-title":"Discovery of alantolactone as a naturally occurring NLRP3 inhibitor to alleviate NLRP3-driven inflammatory diseases in mice","volume":"180","author":"Li","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10787-021-00918-4","article-title":"Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases","volume":"30","author":"Hua","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejmech.2026.119222_bib24","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s10787-023-01199-9","article-title":"Inhibition of STAT3 phosphorylation by colchicine regulates NLRP3 activation to alleviate sepsis-induced acute lung injury","volume":"31","author":"Liu","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejmech.2026.119222_bib25","article-title":"Indolin-2-ones: a new approach to inflammation, targeting LPS via GSK3\u03b2\/NLRP3","volume":"358","author":"Klochkov","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2026.119222_bib26","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1021\/acs.orglett.5c01609","article-title":"Sorbicillalanines A and B, two [6,5,6] hybrid-sorbicillinoid alkaloids from deep-sea-derived Penicillium sp. co-cultured with sponge-derived Setosphaeria sp","volume":"27","author":"Pang","year":"2025","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.119222_bib27","first-page":"421","article-title":"Total alkaloids from Thesium chinense inhibit lipopolysaccharide-induced respiratory inflammation by modulating Nrf2\/NF-\u03baB\/NLRP3 signaling pathway","volume":"23","author":"Li","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109730","article-title":"Marine fungal-derived butyrolactone attenuates intestinal inflammation through MAPK\/NF-\u03baB and NLRP3 signaling pathway","volume":"174","author":"Tang","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib29","article-title":"Discovery, total synthesis, and anti-inflammatory evaluation of naturally occurring naphthopyrone-macrolide hybrids as potent NLRP3 inflammasome inhibitors","volume":"63","author":"Sun","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119222_bib30","doi-asserted-by":"crossref","first-page":"18172","DOI":"10.1021\/jacs.4c06538","article-title":"Sorbremnoids A and B: NLRP3 inflammasome inhibitors discovered from spatially restricted crosstalk of biosynthetic pathways","volume":"146","author":"Zhang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119222_bib31","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153499","article-title":"Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction","volume":"23","author":"Li","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejmech.2026.119222_bib32","article-title":"Isoliquiritigenin attenuates neuroinflammation after subarachnoid hemorrhage through inhibition of NF-\u03baB-mediated NLRP3 inflammasome activation","volume":"103","author":"Zhang","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.119222_bib33","first-page":"977","article-title":"Loganin attenuates osteoarthritis by inhibiting the ROS-NLRP3-IL-1\u03b2 axis and activating the NRF2\/HO-1 pathway","volume":"22","author":"Li","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib34","first-page":"249","article-title":"An inulin-type fructan CP-A from Codonopsis pilosula attenuates experimental colitis in mice by promoting autophagy-mediated inactivation of NLRP3 inflammasome","volume":"22","author":"Zhou","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib44","doi-asserted-by":"crossref","first-page":"167309","DOI":"10.1016\/j.jmb.2021.167309","article-title":"Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of inflammasome inhibition","volume":"433","author":"Dekker","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.119222_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1\u03b2-Processing inflammasome with increased activity in muckle-wells autoinflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2026.119222_bib46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119222_bib47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119222_bib48","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1073\/pnas.0611496104","article-title":"Cryopyrin\/NALP3 binds ATP\/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling","volume":"104","author":"Duncan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2026.119222_bib49","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1021\/acs.jmedchem.3c01370","article-title":"Recent progress and prospects of small molecules for NLRP3 inflammasome inhibition","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets","volume":"23","author":"Vande Walle","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119222_bib51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger?","volume":"327","author":"Schroder","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119222_bib52","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.jmedchem.5b01091","article-title":"Inhibiting the inflammasome: a chemical perspective","volume":"59","author":"Baldwin","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119222_bib54","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119222_bib55","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","article-title":"Human monocytes engage an alternative inflammasome pathway","volume":"44","author":"Gaidt","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2026.119222_bib56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/pharmrev.122.000629","article-title":"Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and Inhibitor-NLRP3 interaction","volume":"75","author":"Ma","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2026.119222_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1861169","article-title":"Direct NLRP3 inflammasome inhibitors for cardiovascular therapeutics: a comparative review of synthetic and natural candidates","volume":"17","author":"Zhen","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib59","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119222_bib60","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119222_bib61","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1021\/acschembio.3c00777","article-title":"Integrated proteomics characterization of NLRP3 inflammasome inhibitor MCC950 in monocytic cell line confirms direct MCC950 engagement with endogenous NLRP3","volume":"19","author":"Zhao","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119222_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175931","article-title":"Research progress of NLRP3 inflammasome and its inhibitors with aging diseases","volume":"957","author":"Yuan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib64","series-title":"Treatment for Cryopyrin Associated Periodic Syndromes (CAPS)","author":"Agarwal","year":"2023"},{"key":"10.1016\/j.ejmech.2026.119222_bib65","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.ejmech.2026.119222_bib66","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2026.119222_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjac190.0935","article-title":"P805 Selnoflast, a potent NLRP3 inhibitor - results from a phase 1b experimental medicine study in patients with ulcerative colitis","volume":"17","author":"Klughammer","year":"2023","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.ejmech.2026.119222_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjac190.0935","article-title":"P805 Selnoflast, a potent NLRP3 inhibitor - results from a phase 1b experimental medicine study in patients with Ulcerative Colitis","volume":"17","author":"Klughammer","year":"2023","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.ejmech.2026.119222_bib69","doi-asserted-by":"crossref","first-page":"14195","DOI":"10.1021\/acs.jmedchem.5c00781","article-title":"Discovery of AZD4144, a selective and potent NLRP3 inhibitor for the treatment of inflammatory diseases","volume":"68","author":"Johansson","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114919","article-title":"Development of novel oridonin analogs as specifically targeted NLRP3 inflammasome inhibitors for the treatment of dextran sulfate sodium-induced colitis","volume":"245","author":"Pang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116760","article-title":"Design, synthesis, and biological evaluation of oridonin derivatives as novel NLRP3 inflammasome inhibitors for the treatment of acute lung injury","volume":"277","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib37","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1021\/acs.jmedchem.4c00504","article-title":"Hit-to-Lead optimization of the natural product oridonin as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activity","volume":"67","author":"He","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib38","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1021\/acs.jmedchem.2c01967","article-title":"Scaffold hybrid of the natural product tanshinone I with piperidine for the discovery of a potent NLRP3 inflammasome inhibitor","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129725","article-title":"Design, synthesis and biological evaluation of tanshinone IIA derivatives as NLRP3 inflammasome inhibitors","volume":"104","author":"Chen","year":"2024","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119222_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114357","article-title":"Discovery of 4-((E)-3,5-dimethoxy-2-((E)-2-nitrovinyl) styryl) aniline derivatives as potent and orally active NLRP3 inflammasome inhibitors for colitis","volume":"236","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/acsmedchemlett.1c00597","article-title":"New highly potent NLRP3 inhibitors: Furanochalcone velutone F analogues","volume":"13","author":"Zhang","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119222_bib42","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1021\/acs.jmedchem.4c00357","article-title":"Novel isoalantolactone-based derivatives as potent NLRP3 inflammasome inhibitors: design, synthesis, and biological characterization","volume":"67","author":"Zhao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib43","doi-asserted-by":"crossref","first-page":"21534","DOI":"10.1021\/acs.jmedchem.5c01663","article-title":"AI-Driven transfer learning and generative model (TransGenGRU) enables the drug discovery of novel natural guaianolide sesquiterpene derivatives as potent NLRP3 inhibitors","volume":"68","author":"Lin","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0934-8840(97)80076-X","article-title":"Antibacterial activity of trichorabdal A from Rabdosia trichocarpa against Helicobacter pylori","volume":"286","author":"Kadota","year":"1997","journal-title":"Zentralbl. Bakteriol."},{"key":"10.1016\/j.ejmech.2026.119222_bib71","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.3390\/molecules19033327","article-title":"Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells","volume":"19","author":"Kuo","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119222_bib72","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejmech.2016.06.015","article-title":"Discovery and development of natural product oridonin-inspired anticancer agents","volume":"122","author":"Ding","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib73","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1248\/cpb.24.2118","article-title":"The antitumor and antibacterial activity of the Isodon diterpenoids","volume":"24","author":"Fujita","year":"1976","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2026.119222_bib74","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11596-009-0525-2","article-title":"Efficacy of Rabdosia rubescens in the treatment of gingivitis","volume":"29","author":"Chen","year":"2009","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.ejmech.2026.119222_bib75","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.intimp.2009.01.002","article-title":"Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia","volume":"9","author":"Xu","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib76","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/jgh.12710","article-title":"Oridonin's therapeutic effect: suppressing Th1\/Th17 simultaneously in a mouse model of Crohn's disease","volume":"30","author":"Wang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2026.119222_bib77","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119222_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117861","article-title":"MCC950 mitigates SIRT3-NLRP3-driven inflammation and rescues post-stroke neurogenesis","volume":"183","author":"Prakash","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119222_bib79","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","article-title":"MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease","volume":"116","author":"Naeem","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejmech.2026.119222_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12504","article-title":"Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models","volume":"7","author":"Daniels","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119222_bib81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome\u2013mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129621","article-title":"Discovery of novel oridonin sulfamide derivatives as potent NLRP3 inhibitors by a visible-light photocatalysis-enabled peripheral editing","volume":"99","author":"Li","year":"2024","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119222_bib83","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jm501371s","article-title":"Organic carbamates in drug design and medicinal chemistry","volume":"58","author":"Ghosh","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib84","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/03602531003745960","article-title":"Qualitative structure-metabolism relationships in the hydrolysis of carbamates","volume":"42","author":"Vacondio","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2026.119222_bib85","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ejmech.2012.03.024","article-title":"The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents","volume":"52","author":"Wang","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib86","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1021\/acs.jnatprod.7b00057","article-title":"6,7-Seco-ent-Kauranoids derived from oridonin as potential anticancer agents","volume":"80","author":"Xu","year":"2017","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.119222_bib87","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ol4015865","article-title":"Overcoming synthetic challenges of oridonin A-Ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-Triazoles at the C-1, C-2, or C-3 position","volume":"15","author":"Ding","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.119222_bib88","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2017.11.018","article-title":"Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer's disease","volume":"129","author":"Maione","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119222_bib89","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/aps.2014.112","article-title":"Tanshinone IIA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice","volume":"36","author":"Xu","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2026.119222_bib90","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2026.119222_bib91","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s10020-023-00671-0","article-title":"Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC","volume":"29","author":"Zhao","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib92","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1021\/acs.jmedchem.8b01018","article-title":"Tanshinone-IIA-Based analogues of imidazole alkaloid act as potent inhibitors to block breast cancer invasion and metastasis in vivo","volume":"61","author":"Wu","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107819","article-title":"Tanshinones inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and gouty inflammation","volume":"97","author":"Yue","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib94","doi-asserted-by":"crossref","first-page":"910","DOI":"10.18632\/aging.202202","article-title":"Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation","volume":"13","author":"Wen","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.ejmech.2026.119222_bib95","article-title":"Tanshinone IIA: a promising natural cardioprotective agent. Evid.-based complement","volume":"2012","author":"Shang","year":"2012","journal-title":"Alternative Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib96","article-title":"Anti\u2010inflammatory and immunomodulatory mechanism of tanshinone IIA for atherosclerosis. Evid.-based complement","volume":"2014","author":"Chen","year":"2014","journal-title":"Alternative Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib97","article-title":"Evaluation of the anti-inflammatory effects of synthesised tanshinone I and isotanshinone I analogues in zebrafish","volume":"15","author":"Singanayagam","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119222_bib98","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.trsl.2014.12.004","article-title":"Therapeutic effect of Cryptotanshinone on collagen-induced arthritis in rats via inhibiting nuclear factor kappa B signaling pathway","volume":"165","author":"Wang","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejmech.2026.119222_bib99","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2016.11.061","article-title":"Anti-inflammatory effect of miltirone on inflammatory bowel disease via TLR4\/NF-\u03baB\/IQGAP2 signaling pathway","volume":"85","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119222_bib100","article-title":"Tanshinone IIA and cryptotanshinone prevent mitochondrial dysfunction in hypoxia-induced H9c2 cells: association to mitochondrial ROS, intracellular nitric oxide, and calcium levels. Evid.-based complement","volume":"2013","author":"Jin","year":"2013","journal-title":"Alternative Med."},{"key":"10.1016\/j.ejmech.2026.119222_bib101","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tem.2017.10.009","article-title":"AMP-activated protein kinase regulation of the NLRP3 inflammasome during aging","volume":"29","author":"Cordero","year":"2018","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejmech.2026.119222_bib102","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.taap.2015.03.010","article-title":"Curcumin attenuates glutamate neurotoxicity in the hippocampus by suppression of ER stress-associated TXNIP\/NLRP3 inflammasome activation in a manner dependent on AMPK","volume":"286","author":"Li","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib103","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2015.05.152","article-title":"Sodium tanshinone IIA sulfonate ameliorates ischemia-induced myocardial inflammation and lipid accumulation in Beagle dogs through NLRP3 inflammasome","volume":"196","author":"Hu","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejmech.2026.119222_bib104","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.intimp.2019.05.006","article-title":"NLRP3 inflammasome as a treatment target in atherosclerosis: a focus on statin therapy","volume":"73","author":"Parsamanesh","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111332","article-title":"A review of the biological activity and pharmacology of cryptotanshinone, an important active constituent in Danshen","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119222_bib106","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10753-019-01124-9","article-title":"The NLRP3 inflammasome and its role in sepsis development","volume":"43","author":"Danielski","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.ejmech.2026.119222_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116478","article-title":"Total tanshinones protect against acute lung injury through the PLC\u03b32\/NLRP3 inflammasome signaling pathway","volume":"314","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2026.119222_bib108","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1021\/acs.jmedchem.9b00246","article-title":"Fixing the unfixable: the art of optimizing natural products for human medicine","volume":"62","author":"Y\u00f1igez-Gutierrez","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib109","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41557-019-0411-x","article-title":"Principle and design of pseudo-natural products","volume":"12","author":"Karageorgis","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib110","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1002\/anie.200200553","article-title":"Natural product hybrids as new leads for drug discovery","volume":"42","author":"Tietze","year":"2003","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119222_bib111","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1039\/D1SC04471K","article-title":"Natural product drug discovery in the artificial intelligence era","volume":"13","author":"Sald\u00edvar-Gonz\u00e1lez","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119222_bib112","doi-asserted-by":"crossref","first-page":"15705","DOI":"10.1002\/anie.202016575","article-title":"Pseudo natural products\u2014chemical evolution of natural product structure","volume":"60","author":"Karageorgis","year":"2021","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119222_bib113","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1021\/acs.jmedchem.6b00473","article-title":"Underexplored opportunities for natural products in drug discovery","volume":"59","author":"DeCorte","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib114","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/1521-3773(20000616)39:12<2099::AID-ANIE2099>3.0.CO;2-Y","article-title":"Natural-product hybrids: design, synthesis, and biological evaluation of quinone-annonaceous acetogenins","volume":"39","author":"Hoppen","year":"2000","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119222_bib115","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/jacs.1c11270","article-title":"Chemical evolution of natural product structure","volume":"144","author":"Grigalunas","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119222_bib116","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1021\/acs.jmedchem.7b01259","article-title":"Structural modification of natural product tanshinone I leading to discovery of novel nitrogen-enriched derivatives with enhanced anticancer profile and improved drug-like properties","volume":"61","author":"Ding","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib117","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1002\/chem.200600813","article-title":"Chiral oxazolopiperidone lactams: versatile intermediates for the enantioselective synthesis of piperidine\u2010containing natural products","volume":"12","author":"Escolano","year":"2006","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2026.119222_bib118","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals","volume":"57","author":"Vitaku","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105661","article-title":"A phytochemical as a promising drug candidate for neurodegenerative diseases","volume":"169","author":"Subedi","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119222_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115750","article-title":"Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: a recent update from 2019 to mid-2023","volume":"260","author":"Duan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib121","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1021\/jm400474r","article-title":"Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)","volume":"56","author":"Liu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib122","article-title":"Chemical evolution and biological evaluation of natural products for efficient therapy of acute lung injury","volume":"11","author":"Fan","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2026.119222_bib123","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1021\/acs.jmedchem.4c02648","article-title":"Peripheral evolution of tanshinone IIA and cryptotanshinone for discovery of a potent and specific NLRP3 inflammasome inhibitor","volume":"68","author":"Zhu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib124","doi-asserted-by":"crossref","first-page":"13633","DOI":"10.1021\/acs.jmedchem.1c01007","article-title":"Discovery of novel pterostilbene-based derivatives as potent and orally active NLRP3 inflammasome inhibitors with inflammatory activity for colitis","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119222_bib125","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/acs.jnatprod.0c00478","article-title":"Flavonoids with inhibitory effects on NLRP3 inflammasome activation from Millettia velutina","volume":"83","author":"Ma","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.119222_bib126","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/np300742d","article-title":"Structural investigation and biological activity of sesquiterpene lactones from the traditional Chinese herb Inula racemosa","volume":"76","author":"Ma","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.119222_bib127","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119222_bib128","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.apsb.2022.09.014","article-title":"Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases","volume":"13","author":"Xu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119222_bib129","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.114.013730","article-title":"Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet","volume":"131","author":"Abderrazak","year":"2015","journal-title":"Circulation"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:01:38Z","timestamp":1793977298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":129,"alternative-id":["S0223523426006677"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119222","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in small-molecule NLRP3 inhibitors derived from natural products","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119222"}}